Hanazuka M, Horii D, Mizogami S
Nihon Yakurigaku Zasshi. 1986 Dec;88(6):433-41. doi: 10.1254/fpj.88.433.
alpha-Adrenoceptor blocking activities and vascular relaxation activities of terazosin, a new antihypertensive agent, were studied. Terazosin had no effect on Ba2+, serotonin, angiotensin II and Ca2+ induced contractions in the isolated rat aorta. Terazosin competitively inhibited norepinephrine (NE) and phenylephrine (PE) induced contractions of the isolated rat aorta, and their pA2 values were 9.28 and 8.74, respectively. The potency of terazosin in the NE induced contraction was about 0.11, 8 and 176 times more than prazosin, phentolamine and yohimbine, respectively. The potency of terazosin in the PE induced contraction was about 0.09, 6 and 60 times more than prazosin, phentolamine and yohimbine. Terazosin (i.v.) competitively inhibited the PE induced pressor response. The "pA2" values of postsynaptic alpha-adrenoceptor blocking activity was 5.22, and its potency was about 0.05, 5 and 62.5 times more than prazosin, phentolamine and yohimbine, respectively. Terazosin (0.3 mg/kg, i.v. or less) did not show any significant effect on clonidine induced bradycardia during electrical stimulation of cardiac sympathetic nerve, whereas prazosin (0.3 mg/kg), phentolamine (0.1 mg/kg) and yohimbine (0.1 mg/kg) antagonized the effect of clonidine by 37%, 80.6% and 63.3%, respectively. Terazosin, 0.3 and 1 mg/kg, p.o., antagonized the PE (3 micrograms/kg, i.v.) induced pressor response in conscious unrestrained rats. This effect lasted for 8 hr in the case of 0.3 mg/kg and lasted for 12 hr in the case of 1 mg/kg. Thus, it is strong suggested that the antihypertensive effect of terazosin is based on the postsynaptic alpha-adrenoceptor blocking action.
研究了新型抗高血压药特拉唑嗪的α-肾上腺素受体阻断活性和血管舒张活性。特拉唑嗪对离体大鼠主动脉中Ba2+、5-羟色胺、血管紧张素II和Ca2+诱导的收缩无影响。特拉唑嗪竞争性抑制去甲肾上腺素(NE)和去氧肾上腺素(PE)诱导的离体大鼠主动脉收缩,其pA2值分别为9.28和8.74。特拉唑嗪对NE诱导收缩的效力分别比哌唑嗪、酚妥拉明和育亨宾高约0.11、8和176倍。特拉唑嗪对PE诱导收缩的效力分别比哌唑嗪、酚妥拉明和育亨宾高约0.09、6和60倍。特拉唑嗪(静脉注射)竞争性抑制PE诱导的升压反应。突触后α-肾上腺素受体阻断活性的“pA2”值为5.22,其效力分别比哌唑嗪、酚妥拉明和育亨宾高约0.05、5和62.5倍。特拉唑嗪(0.3mg/kg,静脉注射或更低剂量)在电刺激心脏交感神经期间对可乐定诱导的心动过缓无显著影响,而哌唑嗪(0.3mg/kg)、酚妥拉明(0.1mg/kg)和育亨宾(0.1mg/kg)分别使可乐定的作用拮抗37%、80.6%和63.3%。口服0.3和1mg/kg的特拉唑嗪可拮抗清醒自由活动大鼠中PE(3μg/kg,静脉注射)诱导的升压反应。在0.3mg/kg的情况下,这种作用持续8小时,在1mg/kg的情况下持续12小时。因此,强烈提示特拉唑嗪的抗高血压作用基于突触后α-肾上腺素受体阻断作用。